TScan Therapeutics Inc. (TCRX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TScan Therapeutics Inc.

    NASDAQ: TCRX · Real-Time Price · USD
    2.11
    -0.07 (-3.21%)
    At close: Oct 03, 2025, 3:59 PM
    2.12
    0.47%
    After-hours: Oct 03, 2025, 04:58 PM EDT

    TScan Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -2.67 -4.29 -0.57 -2.21
    PEG Ratio
    		 0.17 0.09 -0.02 -0.02
    PS Ratio
    		 120.90 18.17 2.75 10.61
    PB Ratio
    		 1.41 2.53 0.37 0.67
    P/FCF Ratio
    		 -2.97 -5.93 -0.53 -1.84
    P/OCF Ratio
    		 -3.07 -6.23 -0.56 -2.21
    OCF/S Ratio
    		 -39.35 -2.92 -4.91 -4.8
    Debt / Equity Ratio
    		 0.40 0.61 0.86 0.04
    Quick Ratio
    		 8.14 6.51 6.94 7.76
    Current Ratio
    		 8.14 6.51 6.94 7.76
    Asset Turnover
    		 0.01 0.08 0.07 0.05
    Interest Coverage
    		 -36.91 -24.86 -56.66 n/a
    Return on Equity
    		 -0.53 -0.59 -0.66 -0.3
    Return on Assets
    		 -0.34 -0.33 -0.33 -0.26
    Return on Invested Capital
    		 -0.39 -0.38 -0.35 -0.29
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 -3.19 0.62 0.67
    Net Profit Margin
    		 -45.28 -4.24 -4.86 -4.79
    Pretax Profit Margin
    		 -45.28 -4.24 -4.89 -4.79
    Operating Profit Margin
    		 -47.88 -4.44 -4.92 -4.8
    FCF Margin
    		 -40.71 -3.06 -5.23 -5.78
    EBITDA Margin
    		 -42.52 -3.81 -4.43 -4.47

    Add to Watchlist